Slide 66 of 76
Notes:
This patient has been on a protease-containing regimen, but has not had complete viral suppression.
His physician would like to change him to a more potent regimen that includes a protease inhibitor with better bioavailability, as well as a drug from another antiretroviral class.
Thus, the regimen the physician is proposing is: ddI, d4T, ritonavir, and delavirdine.
What potential interactions might one anticipate with this regimen?
